Since viral infection was not blocked and EpMs may independently-induce anti-tumor effects, we propose that treatments of IFN, EpMs, and viral infection are compatible with each other in the context of JAK1 minus prostate tumor cells. The gene discussed is JAK1; the disease is viral infectious disease.